JASISConference
”Strategic Bio-banking and Innovation in Medicine”
|
Installation of bio-banking facilities is on progress especially in the major medical research centers, and the accumulation of bio specimen and associated data has been started. From now on, there will be a high expectation for the access to the samples and data, and their utilization by the researchers including industrial developers. In this forum, new ideas of activating bio-banking business models will be introduced and shared by the speakers. Bio-banking will not be successful without the cooperation between academia, government, and industries. Participation of stakeholders are greatly welcome.
| Chair | Dr. Hiroki Nakae JMAC／CIBER Dr. Hiroyuki Kobayashi AxceleadDrug Discovery Partners Inc.／CIBER |
| Time | Title | Speaker | Affiliation |
|---|---|---|---|
| 12:00 | Door Open | ||
| 12:30-12:35 | Opening Address | ||
| 12:35-12:50 | Strategic biobanking at the global standard level | Dr. Hiroki Nakae (Chair) |
JMAC／CIBER |
| Dr. Hiroyuki Kobayashi (Chair) |
Axcelead Drug Discovery Partners Inc.／CIBER | ||
| 12:50-13:20 | Ultra low-cost cell-preservation method created by using antifreeze protein | Prof.Sakae Tsuda | National Institute of Advanced Industrial Science and Technology (AIST)/ Faculty of Life Science, Hokkaido University（HU） |
| 13:20-13:50 | Utilization of unmanned aerial vehicles | Dr. Takuma Sadamori | Department of Emergency and Critical Care Medicine, Hiroshima University |
| 13:50-14:20 | Japanese genome reference standards for better biobanking | Dr. Yasunari Yamanaka | RIKEN／CIBER |
| 14:20-14:40 | Break | _ | _ |
| 14:40-15:10 | How to use Biobanks in In-vitro Diagnostic R&D | Mr. Hiroyuki Uchiyama | JACRI/Nissui Pharmaceutical Co., Ltd/CIBER |
| 15:10-15:40 | Pre-competitive collaborations for acceleration of industrial application of Human Microbiome Research | Dr. Jun Terauchi | Japan Microbiome Consortium/ Ono Pharmaceutical Co.Ltd. |
| 15:40-16:10 | Establishment of plasma metabolome and proteome database in human for the promising drug development | Dr. Tomohiro Andou | Axcelead Drug Discovery Partners Inc., Research Division, Integrated Biology, Platform Technology |
| 16:10-16:25 | Introduction of CIBER | Dr. Koh Furuta | Kanagawa Cancer Center／CIBER |
| 16:25-16:55 | Panel Discussion | ||
| 16:55-17:00 | Closing Remarks | Dr. Hiroyuki Kobayashi (Chair) |
Axcelead Drug Discovery Partners Inc.／ CIBER |
 |
Japan Multiplex bio-Analysis Consortium (JMAC) Council for Industrial use of Biological and Environmental Repositories (CIBER) |
 |
Registration will start in late July on the JASIS website.
https://www.jasis.jp/en/
https://www.jasis.jp/en/